Apollo Medical (NASDAQ:AMEH) Stock Rating Upgraded by Zacks Investment Research

Share on StockTwits

Zacks Investment Research upgraded shares of Apollo Medical (NASDAQ:AMEH) from a strong sell rating to a hold rating in a report released on Monday morning, Zacks.com reports.

According to Zacks, “Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient and physician alignment solutions. The company focuses on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Apollo Medical Holdings, Inc. is headquartered in Glendale, CA. “

Separately, ValuEngine raised shares of Apollo Medical from a hold rating to a buy rating in a research note on Tuesday, December 24th.

Shares of AMEH opened at $18.25 on Monday. The firm’s 50 day moving average is $18.25 and its 200-day moving average is $16.97. The stock has a market capitalization of $625.27 million, a P/E ratio of 62.93, a P/E/G ratio of 2.82 and a beta of -0.86. The company has a debt-to-equity ratio of 1.28, a current ratio of 3.05 and a quick ratio of 3.05. Apollo Medical has a 12-month low of $13.02 and a 12-month high of $23.26.

Apollo Medical (NASDAQ:AMEH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.14 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.14. The company had revenue of $156.06 million for the quarter. Apollo Medical had a net margin of 0.88% and a return on equity of 3.16%. As a group, equities research analysts forecast that Apollo Medical will post 0.4 EPS for the current fiscal year.

In other news, CEO Thomas S. Lam bought 10,000 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was bought at an average cost of $16.30 per share, for a total transaction of $163,000.00. Also, major shareholder Physicians Of Californi Allied bought 12,100 shares of the firm’s stock in a transaction on Wednesday, November 20th. The stock was purchased at an average price of $17.77 per share, with a total value of $215,017.00. Over the last quarter, insiders acquired 303,058 shares of company stock valued at $5,428,152. Corporate insiders own 11.83% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the business. JPMorgan Chase & Co. boosted its holdings in shares of Apollo Medical by 113.7% in the second quarter. JPMorgan Chase & Co. now owns 1,733 shares of the company’s stock worth $28,000 after buying an additional 922 shares during the period. Tower Research Capital LLC TRC boosted its holdings in shares of Apollo Medical by 1,518.0% in the second quarter. Tower Research Capital LLC TRC now owns 3,414 shares of the company’s stock worth $57,000 after buying an additional 3,203 shares during the period. Metropolitan Life Insurance Co NY acquired a new position in shares of Apollo Medical in the third quarter worth about $166,000. Barclays PLC boosted its holdings in shares of Apollo Medical by 238.7% in the third quarter. Barclays PLC now owns 13,790 shares of the company’s stock worth $243,000 after buying an additional 9,719 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Apollo Medical by 52.4% in the second quarter. Charles Schwab Investment Management Inc. now owns 19,822 shares of the company’s stock worth $332,000 after buying an additional 6,816 shares during the period. Institutional investors own 15.96% of the company’s stock.

About Apollo Medical

Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Featured Article: What is a short straddle?

Get a free copy of the Zacks research report on Apollo Medical (AMEH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Apollo Medical  Stock Rating Upgraded by Zacks Investment Research
Apollo Medical Stock Rating Upgraded by Zacks Investment Research
NortonLifeLock  Earns Hold Rating from Robert W. Baird
NortonLifeLock Earns Hold Rating from Robert W. Baird
AgroFresh Solutions  Stock Rating Upgraded by Zacks Investment Research
AgroFresh Solutions Stock Rating Upgraded by Zacks Investment Research
Cowen Reaffirms “Buy” Rating for Mersana Therapeutics
Cowen Reaffirms “Buy” Rating for Mersana Therapeutics
QuickLogic  Price Target Raised to
QuickLogic Price Target Raised to
Independent Investors Inc. Sells 1,637 Shares of Exxon Mobil Co.
Independent Investors Inc. Sells 1,637 Shares of Exxon Mobil Co.


 
© 2006-2020 Zolmax.